294 related articles for article (PubMed ID: 29442177)
1. Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in "de-novo" Parkinsonian subjects: a randomized controlled trial with 18-month follow-up.
Ferrazzoli D; Ortelli P; Riboldazzi G; Maestri R; Frazzitta G
J Neurol; 2018 Apr; 265(4):906-916. PubMed ID: 29442177
[TBL] [Abstract][Full Text] [Related]
2. Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc Analysis.
Giladi N; Asgharnejad M; Bauer L; Grieger F; Boroojerdi B
J Parkinsons Dis; 2016 Apr; 6(2):401-11. PubMed ID: 27061066
[TBL] [Abstract][Full Text] [Related]
3. Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome: post hoc analysis of patients with early Parkinson's disease with mild symptom severity.
Timmermann L; Asgharnejad M; Boroojerdi B; Dohin E; Woltering F; Elmer LW
Expert Opin Pharmacother; 2015; 16(10):1423-33. PubMed ID: 25997442
[TBL] [Abstract][Full Text] [Related]
4. A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson's disease.
Woitalla D; Dunac A; Safavi A; Ceravolo MG; Gomez Esteban JC; Pavese N; Asgharnejad M; Joeres L; Schuller JC; Chaudhuri KR
Expert Opin Pharmacother; 2018 Jun; 19(9):937-945. PubMed ID: 29916262
[TBL] [Abstract][Full Text] [Related]
5. Intensive rehabilitation treatment in early Parkinson's disease: a randomized pilot study with a 2-year follow-up.
Frazzitta G; Maestri R; Bertotti G; Riboldazzi G; Boveri N; Perini M; Uccellini D; Turla M; Comi C; Pezzoli G; Ghilardi MF
Neurorehabil Neural Repair; 2015 Feb; 29(2):123-31. PubMed ID: 25038064
[TBL] [Abstract][Full Text] [Related]
6. Land Plus Aquatic Therapy Versus Land-Based Rehabilitation Alone for the Treatment of Freezing of Gait in Parkinson Disease: A Randomized Controlled Trial.
Clerici I; Maestri R; Bonetti F; Ortelli P; Volpe D; Ferrazzoli D; Frazzitta G
Phys Ther; 2019 May; 99(5):591-600. PubMed ID: 30657995
[TBL] [Abstract][Full Text] [Related]
7. Patients' perception of Parkinson's disease-associated pain following initiation of rotigotine: a multicenter non-interventional study.
Timmermann L; Oehlwein C; Ransmayr G; Fröhlich H; Will E; Schroeder H; Lauterbach T; Bauer L; Kassubek J
Postgrad Med; 2017 Jan; 129(1):46-54. PubMed ID: 27883297
[TBL] [Abstract][Full Text] [Related]
8. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).
Trenkwalder C; Kies B; Rudzinska M; Fine J; Nikl J; Honczarenko K; Dioszeghy P; Hill D; Anderson T; Myllyla V; Kassubek J; Steiger M; Zucconi M; Tolosa E; Poewe W; Surmann E; Whitesides J; Boroojerdi B; Chaudhuri KR;
Mov Disord; 2011 Jan; 26(1):90-9. PubMed ID: 21322021
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a Goal-Based Intensive Rehabilitation in Parkinsonian Patients in Advanced Stages of Disease.
Ortelli P; Ferrazzoli D; Bera R; Caremani L; Giladi N; Maestri R; Frazzitta G
J Parkinsons Dis; 2018; 8(1):113-119. PubMed ID: 29480227
[TBL] [Abstract][Full Text] [Related]
10. Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.
Zhang ZX; Shang HF; Hu X; Chen S; Zhao Z; Du X; Surmann E; Bauer L; Asgharnejad M
Parkinsonism Relat Disord; 2016 Jul; 28():49-55. PubMed ID: 27172830
[TBL] [Abstract][Full Text] [Related]
11. Transdermal Patch of Rotigotine Attenuates Freezing of Gait in Patients with Parkinson's Disease: An Open-Label Comparative Study of Three Non-Ergot Dopamine Receptor Agonists.
Ikeda K; Hirayama T; Takazawa T; Kawabe K; Iwasaki Y
Intern Med; 2016; 55(19):2765-2769. PubMed ID: 27725534
[TBL] [Abstract][Full Text] [Related]
12. Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
Antonini A; Bauer L; Dohin E; Oertel WH; Rascol O; Reichmann H; Schmid M; Singh P; Tolosa E; Chaudhuri KR
Eur J Neurol; 2015 Oct; 22(10):1400-7. PubMed ID: 26095948
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.
Giladi N; Nicholas AP; Asgharnejad M; Dohin E; Woltering F; Bauer L; Poewe W
J Parkinsons Dis; 2016 Oct; 6(4):741-749. PubMed ID: 27567886
[TBL] [Abstract][Full Text] [Related]
14. Rotigotine vs ropinirole in advanced stage Parkinson's disease: a double-blind study.
Mizuno Y; Nomoto M; Hasegawa K; Hattori N; Kondo T; Murata M; Takeuchi M; Takahashi M; Tomida T;
Parkinsonism Relat Disord; 2014 Dec; 20(12):1388-93. PubMed ID: 25455692
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of rotigotine monotherapy in early Parkinson's disease.
Parkinson Study Group
Arch Neurol; 2003 Dec; 60(12):1721-8. PubMed ID: 14676046
[TBL] [Abstract][Full Text] [Related]
16. Rotigotine transdermal system for the treatment of Parkinson's disease.
Pham DQ; Nogid A
Clin Ther; 2008 May; 30(5):813-24. PubMed ID: 18555929
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.
Hauser RA; Slawek J; Barone P; Dohin E; Surmann E; Asgharnejad M; Bauer L
BMC Neurol; 2016 Jun; 16():90. PubMed ID: 27267880
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease.
Chung SJ; Asgharnejad M; Bauer L; Ramirez F; Jeon B
Expert Opin Pharmacother; 2016 Aug; 17(11):1453-61. PubMed ID: 27322571
[TBL] [Abstract][Full Text] [Related]
19. Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.
Splinter MY
Ann Pharmacother; 2007 Feb; 41(2):285-95. PubMed ID: 17213296
[TBL] [Abstract][Full Text] [Related]
20. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease.
Watts RL; Jankovic J; Waters C; Rajput A; Boroojerdi B; Rao J
Neurology; 2007 Jan; 68(4):272-6. PubMed ID: 17202432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]